metabolic-diseases

Documents about metabolic-diseases

• Ethnomedicinal Uses, Phytochemistry and Bioactivities of Halophytes and Salt-Tolerant Plants with Potential Against Metabolic Syndrome: A Comprehensive Review#971224HAL (France)
• Electromagnetic Treatment For Bone Loss After Forearm Fracture#1032885ClinicalTrials.gov
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity#826709ClinicalTrials.gov
• Integration of Health Coaching and Diabetes Education in Type 2 Diabetes Mellitus Management at Primary Health Care#803203ClinicalTrials.gov
• Association of corneal nerve parameters with nerve abnormalities and neuropathic pain in prediabetes and type 2 diabetes: the Maastricht Study#130661Springer Nature OA
• Additional file 2 of 1H NMR-based metabolomics reveals metabolic changes in porcine ingesta and serum during Ascaris suum infection#221763Figshare
• Additional file 1 of 1H NMR-based metabolomics reveals metabolic changes in porcine ingesta and serum during Ascaris suum infection#221764Figshare
• Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis#306088Springer Nature OA
• Association between occupational sedentary behavior and metabolic syndrome and related diseases in males: A cross-sectional study#316306PLOS
• Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)#370996IRIS
• Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases#403238OpenAlex
• Task-shifted Adaptation of the WHO-PEN Intervention to Address Cardio-metabolic Complications in People Living With HIV in Zambia#853509ClinicalTrials.gov
• A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose#903276ClinicalTrials.gov
• Supplementary material: IMCL:EMCL ratio relates to insulin resistance and impaired substrate metabolism in MASLD#1002239University of Nottingham Repository
• The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin#121316ClinicalTrials.gov
• Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study#203167Recep Tayyip Erdoğan University Institutional Repository
• Person-centered outcomes for liver glycogen storage diseases: Development of an international consensus-based standard outcome set#388303IRIS
• Effects of HIIT vs. TRE on Type 2 Diabetes Risk#878645ClinicalTrials.gov
• Nutrition and Energy Restriction for Cancer Prevention#892387ClinicalTrials.gov
• Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight#906082ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period#805891ClinicalTrials.gov
• Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial#130677Springer Nature OA
• GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection#319403Springer Nature OA
• Inequalities in type 2 diabetes incidence in a multiethnic population: a cohort study investigating the impact of ethnicity, migration and mental health comorbidities#319406Springer Nature OA
• Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study#362535Recep Tayyip Erdoğan University Institutional Repository
• Brown Fat as Therapeutic Strategy for Obesity and Associated Metabolic Diseases Via Functional Food/Nutraceutical Approach - Molecular Mechanisms of Pentacyclic Triterpenes (BRACE)#826943ClinicalTrials.gov
• Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients#850760ClinicalTrials.gov
• Etude des mécanismes impliqués dans la persistance des AAV dans le foie pour développer une nouvelle génération de vecteurs de thérapie génique#15485HAL (France)
• Co-designing a new clinical pathway to support families with children identified as having early-stage type 1 diabetes in Western Australia#130707Springer Nature OA
• Association between air pollution and incident cardiovascular diseases among a population with cardiovascular-kidney-metabolic syndrome stages 0-3: the first evidence from the China Health and Retirement Longitudinal Study.#351804NCBI PubMed Central
• Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial#416625Springer Nature OA
• SARS-CoV-2 infection and COVID-19 vaccination and the risk for new-onset type 1 diabetes: a register-based population study in Sweden#416626Springer Nature OA
• Sustainable diets and functional foods for the prevention of cardio-metabolic diseases and sustainable development goals of the UNO. An international consensus of scientific statement of the international college of nutrition and 28th world congress on clinical nutrition, Bogor, Indonesia.#348451PubMed
• Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)#881724ClinicalTrials.gov
• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes#894538ClinicalTrials.gov
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg#148714ClinicalTrials.gov
• Nocturnal fat oxidation is lower in older individuals with overweight/obesity, including those with type 2 diabetes, and is associated with fasting triglyceride levels#319398Springer Nature OA
• Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment#373750ClinicalTrials.gov
• Premeal insulin administration lowers postprandial blood glucose and increases myocardial microvascular blood flow in people with type 1 diabetes: a randomised, crossover clinical trial#648558Springer Nature OA
• Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials#826674ClinicalTrials.gov
• Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases#859037ClinicalTrials.gov
• Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults#919007ClinicalTrials.gov
• Environmental and Biological Factors Shaping Metabolic Variation in Potato (Solanum tuberosum L.): A Metabolomics-Based Review#280472HAL (France)
• Gestational diabetes and risk of type 2 diabetes: exploring the role of the gut microbiome in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)#319400Springer Nature OA
• A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes#648532Springer Nature OA
• "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients#904372ClinicalTrials.gov
• Diabetes, Exercise and Liver Fat (DELIVER)#843590ClinicalTrials.gov
• Effect of Intensive Nutrition Training, Education, and Support in Gestational Diabetes - The INTENSE-GDM TRIAL#863404ClinicalTrials.gov
• The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation#130695Springer Nature OA
• A supervised, online, home-based eccentric resistance exercise program for patients with metabolic dysfunction-associated steatotic liver disease#233503Research Online